ClinicalTrials.gg
Sign In

Drug

Omarigliptin clinical trials

Also written MK-3102.

studies test it
17
open now
1
in phase 3
10
first study started
2010

Keep track of what changes. Save the omarigliptin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Omarigliptin
15

Development codes

MK-3102
7

Studies by the year they started

17 studies that test it; most in 2012 (6)

Studies that test omarigliptin, by start year
YearStudies
20102
20111
20126
20135
20161
20171
20241

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
1
Phase 3
10
Phase 4
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Diabetes Mellitus, Type 2
15
Renal Insufficiency, Chronic
1
Renal Insufficiency
1

Who runs them

Industry 15 · Other 2

Merck Sharp & Dohme LLC (15) · British University In Egypt (1) · Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (1)

Often tested with

Tested in the same studies.

Insulin (1) · Trelagliptin (1)

Studies

Open first, then newest update. How each study uses omarigliptin is read from its arms, and is right about nine times in ten.

Testing it · 17

Given in every arm · 1 — omarigliptin is usual care beside what is tested

Codes

What other systems call omarigliptin · ClinicalTrials.gg INT006466

  • UNII (FDA) CVP59Q4JE1OMARIGLIPTINConfirmed FDA, Wikidata
  • Wikidata Q21098979omarigliptinConfirmed FDA, Wikidata
  • NCI Thesaurus C174662OmarigliptinOne source FDA
  • DrugBank DB11992One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.